CAPTRUST FINANCIAL ADVISORS - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,000
-54.5%
1,238
-35.9%
0.00%
Q1 2022$11,000
-26.7%
1,931
-3.8%
0.00%
Q4 2021$15,000
-6.2%
2,008
+13.5%
0.00%
Q3 2021$16,000
-23.8%
1,7690.0%0.00%
Q2 2021$21,000
-65.6%
1,769
-63.9%
0.00%
-100.0%
Q1 2021$61,000
+5.2%
4,900
+31.5%
0.00%0.0%
Q4 2020$58,000
+23.4%
3,727
-25.1%
0.00%0.0%
Q3 2020$47,000
+2.2%
4,979
+2.6%
0.00%0.0%
Q2 2020$46,0004,8510.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders